Oncology
Role of the Pharmacist in the Management of Breast Cancer
The objective of this online program is to help educate and support pharmacists in the Kingdom of Saudi Arabia in understanding the current landscape of breast cancer- genetic mutations, risk factors, and selected newly approved therapies. There is also discussion about common adverse events associated with guideline-recommended treatment of breast cancer, and the role of pharmacists to help mitigate adverse events in their patients.
This program is approved for the following professions: Pharmaceutical Sciences, Clinical Pharmacy, Pharmaceutical administration and outcomes, Pharmacy.
Durée
1 hr
Profession
Pharmacy
# des crédits
1.0
Accréditation
SCFHS
Date d'expiration
2024-07-26
Recent literature demonstrates that breast cancer is now among the top four most frequently diagnosed cancers in the Kingdom of Saudi Arabia (KSA). It is the most common cancer among women in KSA. For women undergoing treatment for breast cancer, pharmacists will play a pivotal role in their health care team.
The objective of this online program is to help educate and support pharmacists in the Kingdom of Saudi Arabia in understanding the current landscape of breast cancer- genetic mutations, risk factors, and selected newly approved therapies. There is also discussion about common adverse events associated with guideline-recommended treatment of breast cancer, and the role of pharmacists to help mitigate adverse events in their patients.
This program is supported by Novartis.
La Faculté
Dr. Abdullah Alsharm
Nora Alkhudair, reviewer
Objectifs d'apprentissage
Upon completion of this continuing education program, participants will be better able to:
- Describe relevant genetic mutations seen in breast cancer.
- Outline risk factors and preventive strategies for breast cancer.
- Integrate information about newly approved therapies into the treatment of breast cancer.
- Recognize common adverse events associated with the treatment of breast cancer and implement strategies to mitigate them.
Accréditation
This program is accredited by the Saudi Commission for Health Specialties for 1.0 CPD Hour(s). Activity Accreditation Number: ACA‐20230002486.
Credits are reported to the Saudi Commission for Health Specialties on a monthly basis. Please ensure that your Saudi Commission ID is accurate in your profile and allow sufficient time for credits to appear in your Mustamir account.
This program is approved for the following professions: Pharmaceutical Sciences, Clinical Pharmacy, Pharmaceutical administration and outcomes, Pharmacy.